A collaboration with the FDA: How Flatiron real-world evidence provides actionable insightsView the ASCO 2017 poster
The clinico-genomic database: Advance personalized medicine with a revolutionary discovery toolView the product summary
How drugs go viral: Flatiron's real-world data show how uptake happensView The Cancer Letter article
Integrated at the source. Expanded with linked data sets.
- Derived from the EHRs of over 265 community clinics and academic institutions at over 800 unique sites of care.
- The largest and highest quality source for real-world evidence in oncology – includes both structured and unstructured data.
- Access longitudinal clinical data, with the ability to link to external data sources like genomics, mortality and closed claims.
Designed to meet the most rigorous quality standards for RWE.
Patent-pending abstraction process carefully augments human expertise with machine learning and other technology-enabled optimizations.
Data Quality Control
Thorough quality assurance and complete data provenance for every data point generated.
Active collaborations with the FDA and NCI to define the requirements and uses for regulatory grade RWE.
This is a complete breakthrough, because this type of data—previously used for publication, some payer support, and outcomes research—has never been used for regulatory support.
Let us tell you more.
We will email you to start the conversation.